Down-regulation of FBP1 by ZEB1-mediated repression confers to growth and invasion in lung cancer cells

被引:0
|
作者
Juan Zhang
Jiangtao Wang
Hui Xing
Qingfeng Li
Qianfeng Zhao
Jing Li
机构
[1] Hubei University of Arts and Science,Department of Oncology, Xiangyang Central Hospital
来源
关键词
Lung cancer; FBP1; Proliferation; Invasion; ZEB1;
D O I
暂无
中图分类号
学科分类号
摘要
Lung cancer is the most common type of malignant tumor, but the molecular mechanisms for lung cancer progression remains to be elusive. Here, we demonstrated that FBP1 (Fructose-1, 6-bisphosphatase) was frequently down-regulated in lung cancer tissues and cells, and FBP1 down-regulation was associated with poor prognosis in lung cancer patients. Restored FBP1 expression inhibited glucose uptake and lactate production, but induced oxygen consumption. Restored FBP1 expression also inhibited lung cancer cells proliferation and invasion under hypoxia in vitro, and inhibited lung cancer growth in vivo. Moreover, we confirmed DNA methylation in the promoter contributed to the decrease of FBP1 expression in lung cancer cells. We identified Zinc finger E-box-binding homeobox 1 (ZEB1) bond to FBP1 promoter to enhance DNA methylation in lung cancer cells. Our findings indicate that the down-regulation of FBP1 is a critical oncogenic event in lung cancer progression.
引用
收藏
页码:331 / 340
页数:9
相关论文
共 50 条
  • [1] Down-regulation of FBP1 by ZEB1-mediated repression confers to growth and invasion in lung cancer cells
    Zhang, Juan
    Wang, Jiangtao
    Xing, Hui
    Li, Qingfeng
    Zhao, Qianfeng
    Li, Jing
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2016, 411 (1-2) : 331 - 340
  • [2] ZFX-mediated down-regulation of FBP1 confers to growth in melanoma
    Wu, Yaoqun
    Ge, Yong
    Lei, Tiechi
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (02): : 1222 - 1230
  • [3] Down-regulation of FBP1 in lung adenocarcinoma cells promotes proliferation and invasion through SLUG mediated epithelial mesenchymal transformation
    Wang, Zhitian
    He, Tianyu
    Lv, Wang
    Hu, Jian
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (02) : 236 - 246
  • [4] Down-Regulation of Fructose-1,6-Bisphosphatase (FBP1) in Triple-Negative Breast Cancer
    Yoon, Esther
    Hennrick, Kenneth
    Mao, Yong
    Volyanskyy, Konstantin
    Dimitrova, Nevenka
    Fallon, John T.
    Zhang, Minhao
    LABORATORY INVESTIGATION, 2016, 96 : 79A - 79A
  • [5] Down-Regulation of Fructose-1,6-Bisphosphatase (FBP1) in Triple-Negative Breast Cancer
    Yoon, Esther
    Hennrick, Kenneth
    Mao, Yong
    Volyanskyy, Konstantin
    Dimitrova, Nevenka
    Fallon, John T.
    Zhong, Minhao
    MODERN PATHOLOGY, 2016, 29 : 79A - 79A
  • [6] TLE1 inhibits anoikis and promotes tumorigenicity in human lung cancer cells through ZEB1-mediated E-cadherin repression
    Yao, Xin
    Pham, Tri
    Temple, Brandi
    Gray, Selena
    Cannon, Cornita
    Hardy, Camry
    Fletcher, Kamari
    Ireland, Shubha Kale
    Hossain, Ahamed
    Chen, Renwei
    Abdel-Mageed, Asim B.
    Biliran, Hector
    ONCOTARGET, 2017, 8 (42) : 72235 - 72249
  • [7] Zeb1-mediated T-cadherin repression increases the invasive potential of gallbladder cancer
    Adachi, Yoshihiro
    Takeuchi, Tamotsu
    Nagayama, Tomoko
    Ohtsuki, Yuji
    Furihata, Mutsuo
    FEBS LETTERS, 2009, 583 (02) : 430 - 436
  • [8] miR-493 mediated DKK1 down-regulation confers proliferation, invasion and chemo-resistance in gastric cancer cells
    Jia, Xiaoting
    Li, Nan
    Peng, Cong
    Deng, Yingen
    Wang, Jia
    Deng, Min
    Lu, Minying
    Yin, Jiang
    Zheng, Guopei
    Liu, Haiying
    He, Zhimin
    ONCOTARGET, 2016, 7 (06) : 7044 - 7054
  • [9] Zeb1-mediated autophagy enhances resistance of breast cancer cells to genotoxic drugs
    Barlev, Nick A.
    Fedorova, Olga
    Daks, Alexandra
    Tulchinsky, Eugene M.
    CANCER RESEARCH, 2023, 83 (07)
  • [10] Down-regulation of miR-144 promotes thyroid cancer cell invasion by targeting ZEB1 and ZEB2
    Guan, Hongyu
    Liang, Weiwei
    Xie, Zhiwei
    Li, Hai
    Liu, Juan
    Liu, Liehua
    Xiu, Lingling
    Li, Yanbing
    ENDOCRINE, 2015, 48 (02) : 566 - 574